Flat 50% Off on All Research Reports! Use code CRISP50 at checkout. Download Now!
Flat 50% Off on All Research Reports! Use code CRISP50 at checkout. Download Now!
Since its spin-off from General Electric in 2023, GE HealthCare has been making significant strides in the medical technology sector. In 2025, the company is reinforcing its position as a leader in medical imaging and artificial intelligence (AI), unveiling groundbreaking technologies and forging strategic partnerships to revolutionise patient care. This focus on GE HealthCare AI Imaging is central to their strategy.
In May 2025, GE HealthCare received FDA clearance for its latest innovation: the Aurora SPECT/CT system. This dual-head scanner integrates gamma-ray-based SPECT hardware with X-ray CT components, expanding its range of procedures across multiple specialities. The system is powered by Clarify DL, a deep learning AI that enhances image clarity and reduces noise, facilitating more accurate diagnoses in cardiology, oncology, and neurology. The first U.S. installation is set for University Hospitals in Cleveland, Ohio. This advancement highlights the power of GE HealthCare AI Imaging.
In 2025, GE HealthCare partnered with NVIDIA to develop smarter, AI-powered imaging systems, beginning with X-rays and ultrasounds—the most widely used medical scans around the world. The goal is to create autonomous imaging technology, where artificial intelligence helps manage tasks like patient positioning, adjusting scan settings, and checking image quality. This would ease the workload for radiologists and technicians, many of whom are overwhelmed by high patient volumes and repetitive tasks.
The need for this innovation is clear. Globally, more than 4 billion X-rays and ultrasounds are performed each year, while around 90% of ultrasound technicians report work-related injuries. In the U.S. alone, over 80% of hospitals face a shortage of imaging staff. With the help of NVIDIA’s advanced AI and virtual testing tools, GE HealthCare is designing smart imaging systems that can be safely developed and tested before being used in hospitals.
These solutions are expected to make imaging more accessible, especially in areas with fewer medical professionals, while helping healthcare workers focus more on patient care. Leaders from both companies see this partnership as a key move toward faster, safer, and more efficient diagnostic imaging in the future.
GE HealthCare Technologies (GEHC) reported solid financial results for Q1 FY25, with revenue reaching $4.8 billion, marking a 3% increase on a reported basis and 4% organic growth compared to last year. Growth was seen across all segments, with particularly strong performance in the U.S. Organic orders rose by a record 10%, and the book-to-bill ratio stood at 1.09—indicating healthy demand momentum.
Profitability also improved significantly. Net income rose to $564 million, up from $374 million a year ago. Adjusted EBIT grew to $715 million (from $681 million), with the adjusted EBIT margin improving to 15.0%, supported by higher volume and productivity gains. Net income margin increased to 11.8%, and diluted EPS climbed to $1.23 (up from $0.81), while adjusted EPS rose to $1.01, helped by stronger operating income and lower interest and tax expenses.
However, GEHC continues to face significant headwinds from U.S.-China tariffs, which are expected to impact earnings by $0.85 per share in 2025, with $375 million of the $500 million total impact coming from China-related tariffs. These tariffs affect exports of key imaging components like X-ray and MRI parts. While GEHC is actively working to mitigate the impact, including localising its supply chain across its 43 manufacturing sites, these efforts will take time. A potential improvement in trade relations could result in a $0.40 per share benefit, but GEHC is not relying on this scenario.
GE HealthCare is making significant strides in advancing medical imaging and artificial intelligence, positioning itself as a leader in the healthcare technology sector. With the launch of the Aurora SPECT/CT system and its collaboration with NVIDIA to develop autonomous imaging solutions, GE HealthCare is shaping the future of patient care by enhancing the accuracy, accessibility, and efficiency of diagnostic tools. Despite facing challenges from U.S.-China tariffs, the company has demonstrated strong financial growth in Q1 FY25, showing resilience and adaptability in a dynamic market.
GE HealthCare, headquartered in Chicago, is a global leader in medical technologies and digital solutions. It offers innovative products in imaging, diagnostics, and biomanufacturing, with a strong focus on artificial intelligence (AI) to enhance healthcare outcomes. After spinning off from General Electric in 2023, the company continues to drive advancements in healthcare through cutting-edge technologies and solutions.
Interested in more analysis of healthcare trends and technologies? Discover CrispIdea blogs.
